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Introduction
Two decades ago, cancer of the esophagus in the
East and in the West was a squamous cell cancer of
the intrathoracic esophagus, situated predominantly
in the middle third. Today, in the East, this remains
largely unchanged. In the West, however, the disease
has become a Barrett’s adenocarcinoma of the distal
esophagus, as a consequence of gastroesophageal reflux
and dysplasia occurring in specialized intestinal meta
plastic epithelium.L2Indeed, this condition is epidemic
in the West and has, like obesity, become a major health
issue. Furthermore, while the epidemiology in the
East has remained unchanged, in the West, Barrett’s
cancer primarily affects the professional middle-age
Caucasian, unlike the older blue-collar worker in the
past who habituates cigarettes and alcohol. As aware
ness increases in the West, the disease is diagnosed
at an increasingly early stage and treatment instituted
in a more timely manner. In the East, diagnosis still
relies on the symptoni of dysphagia which usually
indicates advanced disease. Treatment is therefore in
many instances palliative,
A combination of both the type of patients and the
nature of the disease renders the option of treatment to
be fundamentally different, which then has an impact
on the risks and results of the chosen therapy. By and
large, treatment in the East for squamous cell carci
noma still mandates a thoracotomy, while in the West,
the procedure has increasingly become a transhiatal
approach. While it is expected that the mortality and
morbidity rates should be lower in the West, this has
not been shown to he so and the mortality rate remains
at around 10-I 2%.30 In the East, no data comparable to
the Veterans Affairs database is available but a survey
of 13 hospitals in Hong Kong also revealed a hospital
mortality rate of about l0%, Thus esophagectomy is
still one of the highest risk procedures whether in the
East or West.
Causes of Hospital Mortality
Two decades ago, the mortality rate for esophageal
cancer worldwide was around 30%,’ Like other cen
ters with an interest in dealing with this condition, we
embarked on a systematic approach to reduce this high
rate. The first step was to collect reliable prospective,
almost real-time data on all aspects of the patient
episodes in hospital, including both operative and
non-operative treatment, From this, starting in 1982
we could identify precisely what were the incidences
ofeach cause of death. At around that time, the hospital
mortality rate was 20%.
Medical Causes
The major causes were categorized as medical, surgi
cal and malignant cachexia. The most common cause
(45%) was pulmonary, which was not surprising given
the average age of the patients (65 years), a male
preponderance of 5: 1, their smoking habits and most
of whom underwent a transthoracic resection (72%).
Identifying relevant predictive factors for pulmonary
complications was important to improve outcome.7Our
strategy to reduce this single most important complica
tion was to: (1) enlist a good anesthetist, (2) implement
epidural analgesia and patient-controlled analgesia,9
(3) use a smaller thoracotomy, (4) insert a small (18
Fr) vacuum suction chest drain,9 (5) practise early
extubation in the operating room, (6) perform regular
postoperative bronchoscopic sputum clearance,Lo (7)
ambulate the patient from the first postoperative day,
(8) maintain fluid restriction and albumin level, (9)
perform a tracheostomy early to aid sputum suction
when the coughing effort was inadequate, and (10)
institute vigorous chest physiotherapy. Although even
with all these and other supportive measures pulmonary
complications were not eliminated, the incidence was
lowered and, more importantly, the seriousness had
been mitigated through early intervention. This is a
theme that is relevant in the management of all other
complications of esophagectomy. Cardiac complica
tions (12%) were mostly atrial arrhythmia, and the
availability of effective drugs made for rapid restora
tion of sinus rhythm.0
Surgical Causes
As for surgical complications, technical aspects are
most important in preventing this occurrence ,Anasto
motic leak was and remains a complication that strikes
John Wong MD
HAWALL MEOLCAL JOURNAL. VOL. 63. JULY 2.004
203
fear in the heart of all esophageal surgeons, and has the same effect
on us as anyone else. By examining the problem objectively and
instituting solutions supported by randomized controlled trials, we
have reduced leak rate that was in excess of 25% to now around
2% that are clinically in nature, and another 1% radiologically.4
Changes in technique were made from a hand-sewn two layers of
interrupted suture (before 1982), to the circular stapler, and in the
last 8 years to a single-layercontinuous suture using a4/0 absorbable
suture. H What is equally important is our willingness, indeed our
obsession, to re-explore a patient, even through a re-thoracotomy,
when the patient is not progressing well and no other cause is obvi
ous, or when there is the slightest suspicion of a leak. As all surgeons
are aware, how well the anastomosis was constructed technically at
operation usually forewarn the risk of an anastomotic leak,
Other surgical complications are not common if care to detail
is exercised at the operation. Postoperative bleeding, gangrene of
conduit, chylothorax, bowel herniation into the chest, gastric outlet
obstruction,78and others should be recognized early and treated.
Progressive Malignancy
Death from progressing malignancy after a prolonged stay in hos
pital following a successful operation is a situation specific to the
social environment in [long Kong and to our hospital. Previously,
because alternative treatments were ineffective and associated with
considerable risks, we were prepared to resect (orto bypass using the
Kirschner operation)’920 even in the face of very advanced disease
and operative risks. Although the majority ofpatients recovered from
these procedures and were ambulant and eating normally, they were
not discharged from the convalescent hospital to which they were
transferred because of social problems such as poor family support,
living in the upper floors or roofs of buildings without elevators and
sharing cooking and toilet facilities, and emotionally, physically
and financially unable to cope by themselves. We have therefore
always used hospital mortality rate as the end point of success of an
operation and not the 30-day mortality rate, To include deaths as a
direct result of a technical complication of the operative procedure,
as had been used in the past by those who wished to present good
results, does not reflect the true burden carried by patients after an
esophagectomy. As with the holistic view of a surgeon’s mission, we
hold that success is only achieved when a patient can be discharged
to his previous environment to enjoy what has been possible prior
to the illness that sought our help, and, in the case of esophageal
cancer, this is the ability to eat. We recognize social circumstances
as a cause of hospital mortality may not be a universal problem, but
at least it is a consistently measurable end point.
Over the years, using the approach outlined, the hospital mortal
ity rate has decreased from about 20% to 1%. From 1996 till 1999,
we had no deaths for 169 consecutive resectkns. Since then, there
were three — the first was an elderly female patient who recovered
fully from the operation and died from a myocardial infarction as
she was transferred to a medical ward on day 38. The second was
a gentleman who had undergone prior resection for his head and
neck cancer. A successful esophagectomy was performed but he
died from fulminant recurrence of the head and neck cancer on
day 56. The third patient died from SARS-like illness on day 17
postoperatively.
Changes in Management
During the period of improvement, there have also been advances
in technology and drugs which are more effective and safer than
previously. This allowed us to better select patients ftr appropriate
treatment. Examples of such advances include the self-expanding
metallic stents,2’improved radiation techniques, and effective che
motherapy and combinations of them.
Thus there has been a reduction of the proportion of patients who
underwent resection from about 70% to 55%. and, in particular,
introduction of chemoradiation has made this possible.22 On the
other hand, the referral pattern to our hospital has now included
more patients with more advanced disease. Coincidentally, it was
noteworthy that the mortality rate was halved at a time when our
resection rate was at its’ peak in the early 1 990s. Therefore, the virtual
elimination of postoperative death cannot he attributed to patient
selection alone, but is more likely due to the practice that had been
adopted cited earlier.
Benefits of Reducing Mortality
What are the benefits of improving the operative results? First and
foremost is that survival is prolonged. In our cohort of patients, the
reduction in mortality from 20% to 1% has increased median survival
from 8.6 months to 17.9 months and 5-year survival rate from 18.5%
to24,5%. However, some of the gain may be in part due to the ef
fectiveness of chemotherapy and radiotherapy because even when
hospital deaths were excluded from calculation of survival, there
remains a significant improvement in survival in recent years.22
Second, as deaths usually follow complications, and these are
managed aggressively, there are the savings from reducing the
number of these ill patients who are usually in the ICU. Patients
with anastomotic leak. forexample, would require repeated episodes
of imaging, a variety of radiological and operative procedures.
ventilatory support, parenteral nutrition, third or fourth generation
antibiotics, and an immense amount of attention by surgeons. nurses
and allied health personnel.
Third, the surgical community benefits because of the aura of
good if not excellent results which encourages referral for operative
treatment. Most would agree that a successful operation still offers
the best palliation in terms of quality of swallowing and the widest
variety of food that can be consumed. Cure is now also a distinct
possibility. The need for further treatment in hospital to relieve
dysphagia from persistence or recurrence of the primary tumor, such
as from radiation stricture, is virtually eliminated. An uneventful
surgical resection still offers the best chance of long-term survival,
and is the most cost-effective.
Fourth, the argument that non-operative treatment offers less risk
of death and complications cannot be sustained if resection mortality
and morbidity rates can be achieved at the same if not lower levels
than, say, chemoradiation. This is now a verifiable claim.
Fifth, the morale and confidence of patients and relatives are lifted
knowing they are being managed by a team with an excellent track
record. This in turn puts the responsibility on the surgical team to
perform even better to ensure that trust has not been misplaced.
Sixth and finally, the impact of superior results are not lost to the
administration when formulating policy or distributing resources.
It is hard to ignore or argue against success.
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Conclusion
In conclusion, improvements are possible and achievable. However,
progress is slow and so requires persistence. Improvements are also
incremental and therefore there is no single remedy that changes
outcome overnight. Advancement comes from a team and not just
the operating surgeon, as the assistants, residents and house staffs all
contribute to the minuteto-minute and day-to-day care these patients
need. Progress also occurs through input from other disciplines,
particularly anesthesiologists (epidural analgesia), intensive care
specialists and nurses whose diligence helps detect complications
earlier. Improvements are not more costly, and in fact the reduction
of complications derives major cost savings. Improvements are also
inevitable because in the current environment of surgical practice
those who do not or cannot produce acceptable if not superior
results will not be tolerated by their peers, the administration, or
the community.
To achieve improvement take vigilance, commitment and long
hours, It will also require honest auditing, nourished by studies such
as randomized controlled trials to advance knowledge. Finally, to
reach the level of excellence aspired requires the will and determi
nation to succeed.
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Editor’s Note:
This paper was presented at the 26th Congress of the Pan-Pacific
SurgicalAssociation, February 14-16, 2004, in Honolulu. The C’on
gress, chaired by Torn Kosasa Ml) was outstanding. Look forward
to the next Pan-Pacific Congress — world class researchers and
practicers of the surgical specialties will again return to Hawaii in
January 14-16. 2006.
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